AstraZenca begins trial for new COVID-19 antibody treatment
Tuesday, August 25, 2020 - 08:00
in Health & Medicine
Multinational pharmaceutical company AstraZeneca announced Tuesday that it has started a clinical trial for an antibody therapy intended to prevent and treat COVID-19.